To determine if exogenously administered superoxide dismutase is efficacious in the prevention of bronchopulmonary dysplasia in preterm infants at risk for bronchopulmonary dysplasia.
This is a protocol.
Cochrane
Trusted evidence.
Informed decisions.
Better health.